1 |
Omalizumab |
Omalizumab |
1件: D05251 D05251 💬 |
FCER1A 1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
046 7件: 46, 53, 65, 98, 162, 226, 299 💬 |
2 |
Omalizumab (xolair) |
Omalizumab |
1件: D05251 D05251 💬 |
FCER1A 1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
065 1件: 65 💬 |
3 |
Recombinant humanized monoclonal antibody omalizumab to ige |
Omalizumab |
1件: D05251 D05251 💬 |
FCER1A 1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
299 1件: 299 💬 |
4 |
Rituximab combined with omalizumab |
Omalizumab |
2件: D02994 D02994, D05251 D05251 💬 |
FCER1A 2件: FCER1A, MS4A1 💬 |
Asthma 5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
162 1件: 162 💬 |
5 |
Xolair |
- |
- |
- |
- |
046 2件: 46, 299 💬 |
6 |
Xolair 150 mg pulver und injektionslösung zur herstellung einer injektionslösung |
- |
- |
- |
- |
299 1件: 299 💬 |